Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 USD | -1.30% | +2.01% | +7.04% |
Feb. 14 | Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024 | |
Feb. 14 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Aytu Bioscience
68.7
%
| 61 | 63.2 % | 74 | 68.7 % | +20.74% |
Aytu Consumer Health
31.3
%
| 36 | 36.8 % | 34 | 31.3 % | -5.48% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
99.6
%
| 95 | 97.9 % | 107 | 99.6 % | +13.01% |
International
0.4
%
| 2 | 2.1 % | 0 | 0.4 % | -76.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 15-04-15 |
Jarrett Disbrow
FOU | Founder | 49 | 15-04-15 |
Mark Oki
DFI | Director of Finance/CFO | 55 | 22-01-16 |
Margaret Cabano
COO | Chief Operating Officer | - | 04-12-31 |
Russell McMahen
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Greg Pyszczymuka
PRN | Corporate Officer/Principal | - | - |
Suzane Kennedy
LAW | General Counsel | - | 18-05-31 |
Ryan J. Selhorn
PRN | Corporate Officer/Principal | 42 | - |
Victoria Cordova
HRO | Human Resources Officer | - | 23-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Vivian Liu
BRD | Director/Board Member | 62 | 22-06-30 |
Jarrett Disbrow
FOU | Founder | 49 | 15-04-15 |
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 15-04-15 |
John Donofrio
BRD | Director/Board Member | 56 | 16-07-11 |
Carl Dockery
BRD | Director/Board Member | 61 | 16-04-12 |
Abhinav Jain
BRD | Director/Board Member | 33 | 23-06-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,567,597 | 5,373,596 ( 96.52 %) | 0 | 96.52 % |
Company contact information
Aytu Biopharma, Inc.
7900 East Union Avenue Suite 920
80237, Englewood
+720 437 6580
http://www.aytubio.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.04% | 16.93M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Aytu BioPharma, Inc. - Nasdaq
- Company Aytu BioPharma, Inc.